BioCardia’s Cell Therapy System for Heart Failure Gets FDA Breakthrough Device Designation
CardiAMP Cell Therapy technology uses a patient’s bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure.
CardiAMP Cell Therapy technology uses a patient’s bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure.
CardiAMP Cell Therapy technology uses a patient’s bone marrow cells delivered to the heart in a minimally invasive, catheter-based procedure.